Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesTennesseeRecruitingNCT00079001
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaTennesseeRecruitingNCT00132301
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerTennesseeRecruitingNCT00309985
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerTennesseeRecruitingNCT00430183
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerTennesseeRecruitingNCT00499408
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerTennesseeRecruitingNCT00567580
Salvage Cryotherapy in Recurrent Prostate CancerTennesseeRecruitingNCT00824928
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesTennesseeRecruitingNCT00874211
A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Androgen-Deprivation TherapyTennesseeRecruitingNCT00925600
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerTennesseeRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerTennesseeRecruitingNCT00942331
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate CancerTennesseeRecruitingNCT00953277
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckTennesseeRecruitingNCT01059643
Imaging of Residual Tumor During ProstatectomyTennesseeNot yet recruitingNCT01173146
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerTennesseeRecruitingNCT01188187
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerTennesseeRecruitingNCT01193257
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerTennesseeAvailableNCT01217697
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerTennesseeRecruitingNCT01234311
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerTennesseeRecruitingNCT01288911
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.TennesseeRecruitingNCT01302054
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineTennesseeRecruitingNCT01302067
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerTennesseeRecruitingNCT01306890
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerTennesseeRecruitingNCT01308580
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenTennesseeRecruitingNCT01314118
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate CancerTennesseeRecruitingNCT01322490
Effectiveness of Open and Robotic ProstatectomyTennesseeRecruitingNCT01325506
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple MyelomaTennesseeRecruitingNCT01353625
A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical ProstatectomyTennesseeRecruitingNCT01371994
Safety Study of MGA271 in Refractory CancerTennesseeRecruitingNCT01391143
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerTennesseeRecruitingNCT01415960
A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) DeficiencyTennesseeRecruitingNCT01458067
A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic CancersTennesseeRecruitingNCT01460134
Study of GDC-0068 Or GDC-0980 With Abiraterone Acetate Versus Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyTennesseeNot yet recruitingNCT01485861
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsTennesseeNot yet recruitingNCT01567462
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate CancerTennesseeRecruitingNCT01620515
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyTennesseeAvailableNCT01606982
A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone AcetateTennesseeRecruitingNCT01517802